Hepatitis Flashcards

1
Q

The Hepatitis affect DNA

A

HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The only Fecal Oral transmitted Hepatitis

A

HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The only Hepatitis that not become chronic or cause cirrhosis and HCC

A

HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hepatitis Vaccine

A

HAV, HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Immune due to Vaccination

A

Anti-HBs (+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Immune due to natural

A

Anti-HBs + Anti-HBc (+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Infection

A

HBsAg (+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute infection

A

IgM antiHBc (+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

4 Possibilities associated with HBsAg -, anti-HBc + and anti-HBs -

A

1 . resolved infxn

  1. false +
  2. low level chronic infection (false - for HBsAg)
  3. Resolving Acute infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Five treatment for HCV

A
  1. Ledipasvir/sofosbuvir
  2. Paritaprevir/r/ombitasir+ dasabuvir +/- RBV
  3. Simeprevir + sofosbuvir +/- RBV
  4. sofosbuvir + RBV
  5. PEG-interferon + sofosbuvir + RBV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors affect HCV treatment

A
Genotype 
Presence of cirrhosis 
DDI 
Renal 
CI 
clinical trial evidence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ledipasvir/sofosbuvir

Harvoni

A

daily dose
CI: CrCl<30
required acid environment
not recommoned co-administration with statin

12 weeks treatment for all G1 type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Paritaprevir/r/ombitasvir + dasabuvir
(Viekira pak

+/- RBV

A

complected dosing
DDIs in CYP
photosensitivities
Risk of HIV-1 protease inhibitor resistance in HIV co-infect.
Max of 10mg rosuvastatin, 40mg of pravastatin daily
if used with ribavirin, ↑risk of ALT elevations, risk of HIV-1 protease inhibitor resistance in HIV co-infection

W/ RBV for all G1a
W/O RBV for all G1b

mostly 12 weeks except 1a cirrhosis for 24 wks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

simeprevir

Olysio

A

Take one 150mg capsule once daily with food
sulfa allergy
DDIs with Cobicistat, Efavirdine, delavirdine, etravirine, nevirapine, ritonovir
limited statin doses
Rosuvastatin 10mg, Atorvastatin 40mg

normally use with SOF
for all G1 12 wks
if cirrhosis 24 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute Hepatitis presentation

A

Flu-like illness(malaise, fatigue, myalgia, arthralgia), anorexia, nausea, vomiting, abdominal pain, clay colored stool, dark urine, jaundice, icterus (yellowing of eyes from ↑bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HBV treatment

A

Tenofovir 300mg PO daily – 1st line: Renal dose adjustment Entecavir 1mg PO daily- 1st line: Renal dose adjustment Lamivudine 100mg PO daily- 2nd line: Renal dose adjustment (dosing in HIV is 150mg PO BID or 300mg PO daily)

17
Q

HBV monitoring

A

Viral load q 3-6 month
renal/liver function
in HBsAg Pt monitor seroconversion

18
Q

Sofosbuvir

sovaldi

A

400mg PO daily
CI: CrCl <30
(when given with RBV or PEG-IFN + RBV) diarrhea, anemia, headache, insomnia, fatigue

DDI:Tipranavir/r
St. John’s Wort
Anticonvulsants (CBZ, PHE, PHB, OXZ)
Antimycobacterials (rifampin, rifabutin, rifapentine)

19
Q

Ribavirin (RBV)

A

Usually weight-based:
If ≤ 75kg 1000mg daily (400mg in AM, 600mg in PM) with food
If > 75kg 1200mg daily (600mg in AM, 600mg in PM) with food

SE: bone marrow suppresion
BBW: cardiac disease, Hgb <8, Pregnancy X - need contraception for 6 month after completion of treatment for both partners
No effect as mono therapy

20
Q

G1a no cirrhosis

A

Ledipasvir/sofosbuvir x 12 weeks**
Paritaprevir/r/ombitasvir + Dasabuvir + RBV x 12 weeks
Simeprevir + sofosbuvir ± RBV x 12 weeks

21
Q

G1a cirrhosis

A

Ledipasvir/sofosbuvir x 12 weeks
PTV/r/OBV + DSV + RBV x 24 weeks
Simeprevir + sofosbuvir ± RBV x 24 weeks

22
Q

G1b no cirrhosis

A

LDV/SOF x 12 weeks**
PTV/r/OBV + DSV x 12 weeks (notice no RBV)
SIM/SOF x 12 weeks (notice no RBV)

23
Q

G1b cirrhosis

A

LDV/SOF x 12 weeks
PTV/r/OBV + DSV + RBV x 12 weeks
SIM/SOF x 24 weeks

24
Q

Class of HCV treatment drugs

A

Protease Inhibitors - previr
NS5A inhibitor - asvir
NS5B Polymerase Inhibitors - buvir